PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
28-Apr-2020 NICE RECOMMENDS STELARA® (USTEKINUMAB) FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS The Janssen Pharmaceutical Companies of Johnson & Johnson
28-Apr-2020 Pneumagen Ltd Announces Positive Anti-Viral Activity for Novel Glycan Approach in Preventing Coronavirus (COVID-19) Infections Pneumagen Ltd
28-Apr-2020 Bulletin from Moberg Pharma’s Extraordinary General Meeting on April 28th, 2020 Moberg Pharma
28-Apr-2020 Prokarium Signs an Exclusive Option Agreement with the Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois - CHUV) for the treatment of non-muscle invasive bladder cancer (NMIBC) Prokarium
28-Apr-2020 NICE RECOMMENDS STELARA® (USTEKINUMAB) FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS Janssen
27-Apr-2020 Top-Level industry professionals to speak at Pain Therapeutics Conference in 2 weeks SMi Group
27-Apr-2020 Phase 3 trial of Libtayo® (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival Sanofi
27-Apr-2020 Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients Sanofi
27-Apr-2020 ARTES Joins Global Combat against Corona ARTES Biotechnology
27-Apr-2020 Valo Therapeutics to Support Development of a Pan – Coronavirus Vaccine Valo Therapeutics
27-Apr-2020 Lokelma US label updated to include dosing guidance for the treatment of hyperkalaemia in patients with end-stage renal disease on haemodialysis Label update is based on data from Phase IIIb DIALIZE trial AstraZeneca
27-Apr-2020 Mental health care company COMPASS Pathways concludes successful Series B investment round $80m raised will further the development of psilocybin therapy COMPASS Pathways
27-Apr-2020 Research into medicinal cannabis for treatment of coronavirus ANANDA DEVELOPMENTS PLC
27-Apr-2020 MDxHealth Announces Growth Investment from MVM Partners MDxHealth SA
27-Apr-2020 Development of rapid, point of care, immunodiagnostic test for detection of the SARS-CoV-2 (COVID-19) Leinco Technologies
27-Apr-2020 Santhera and Cold Spring Harbor Laboratory to Investigate Lonodelestat (POL6014) in COVID-19-related Acute Respiratory Distress Syndrome (ARDS) Santhera Pharmaceuticals
27-Apr-2020 ATAI Life Sciences announces close of $24 million convertible note financing round and welcomes Jason Camm of Thiel Capital to Board of Directors ATAI Life Sciences
27-Apr-2020 NanoPass Is Joining Forces with Pharma Partners in The Fight Against The COVID-19 Pandemic NanoPass
24-Apr-2020 Workshop Overview for Oligonucleotide Therapeutics and Delivery 2020 SMi Group Ltd
24-Apr-2020 Exclusive interview with Team Consulting released for Injectable Drug Delivery 2020 SMi Group Ltd